Abstract
An analysis of modern concepts of the mechanism of the antiradiation effect of alpha1-adrenergic agonists, which are of great interest in clinical practice of radiochemotherapy in cancer patients, has been carried out. The first explanation of their mechanism of action is based on the role of circulatory hypoxia in radiosensitive tissues due to the vasoconstrictor effect of alpha1-adrenergic agonists. During further study of the real decrease in oxygen tension in tissue under circulatory hypoxia, it was found that it is insufficient to fully provide the observed increase in the body’s radioresistance under their influence. The second important fact is that in the course of a decrease in the baseline oxygen consumption per unit of body weight when passing from small to large animals, the antiradiation effect of circulatory and hypoxic hypoxia decreases due to the great adaptive abilities in maintaining oxygen homeostasis of the cell under these conditions. This point is directly related to humans. To explain the high radiation protection in large animals under the influence of alpha1-adrenergic agonists, a hypothesis on the development of acute tissue hypoxia due to the intensification of oxygen consumption under alpha1-adrenergic receptor stimulation has been proposed. The third thesis is that alpha1-adrenergic agonists can stabilize mitochondrial homeostasis under exposure to radiation, thereby reducing the probability of radiation apoptosis of cells and maintaining optimal tissue functioning. All three noted components of the mechanism of the antiradiation effect of alpha1-adrenergic agonists can interact with each other, leading to high protection. The role of each component can change and dominate for each specific scenario of their practical application.
Similar content being viewed by others
REFERENCES
J. L. Gray, E. J. Moulden, J. T. Tew, and H. Jensen, Proc. Soc. Exp. Biol. Med. 79 (3), 384 (1952).
Z. M. Bacq, Acta Radiol. 41 (2), 47 (1954).
Z. M. Bacq, A. Herve, J. Lecomte, et al., Arch. Int. Physiol. 59 (4), 442 (1951)
H. Nakatsuka, Y. Shakudo, and M. Fujino, Nihon Igaku Hoshasen Gakkai Zasshi 26, 437 (1966).
K. N. Prasad and M. H. Van Woert, Radiat. Res. 37 (2), 305 (1969).
L. F. Semenov and E. A. Prokudina, Med. Radiol. 2 (3), 35 (1957).
M. M. Konstantinova and E. Ya. Graevskii, Dokl. Akad. Nauk SSSR 133, 1427 (1960).
A. D. Smith, M. J. Ashwood-Smith, and D. Lowman, Nature 184 (22), 1729 (1959).
H. Nakatsuka and H. Ochi, Nippon Igaku Hoshasen Gakkai Zasshi 26 (8), 993 (1966).
C. Prouillac, B. Celaries, P. Vicendo, et al., C. R. Biol. 329, 196 (2006).
A. Mourret, C. Agnius-Delord, and R. Rinaldi, C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 275, 1575 (1972).
A. Mourret, C. Agnius-Delord, C. Martinet, et al., C. R. Acad. Sci. Hebd, Seances Acad. Sci. D 279, 1963 (1974).
J. P. Caravel and C. Luu Duc, Farmacol. Prat. 36, 49 (1981).
V. I. Kulinskii and A. D. Klimova, Radiats. Biol. Radioekol. 33 (5), 681 (1993)
L. A. Il’in, N. M. Rudnyi, N. N. Suvorov, et al., Indralin, an Urgent Radioprotector: Antiradiation Effects, Pharmacology, Mechanism of Action, Clinical Practice (RF Ministry of Health, Moscow, 1994) [in Russian].
M. V. Vasin, G. A. Chernov, L. V. Koroleva, et al., Radiats. Biol. Radioekol. 36 (1), 36 (1996).
M. V. Vasin, V. V. Antipov, G. A. Chernov, et al., Radiats. Biol. Radioekol. 37 (1), 46 (1997).
M. V. Vasin, G. A. Chernov, and V. V. Antipov, Radiats. Biol. Radioekol. 37 (6), 896 (1997).
I. S. Kolesnichenko, L. S. Mikhailov, A. S. Boyarinov, and A. V. Grishin, Veterinariya, No. 12, 52 (2005).
V. S. Shashkov, V. I. Efimov, M. V. Vasin, et al., Aviakosm. Ekol. Med. 44 (1), 15 (2010).
M. V. Vasin, L. F. Semenov, N. N. Suvorov, et al., J. Radiat. Res. 55 (6), 51049 (2014). https://doi.org/10.1093/jrr/rru046
M. V. Vasin, G. A. Chernov, L. V. Koroleva, et al., Radiats. Biol. Radioekol. 36 (2), 168 (1996).
M. V. Vasin, I. B. Ushakov, and N. N. Suvorov, Radiats. Biol. Radioekol. 38 (1), 42 (1998).
M. V. Vasin, I. B. Ushakov, L. A. Semenova, et al., Radiats. Biol. Radioekol. 39 (2–3), 249 (1999).
M. D. Pomerantseva, L. K. Ramaiya, M. V. Vasin, and V. V. Antipov, Russ. J. Genet. 39 (9), 1092 (2003).
M. V. Vasin, I. B. Ushakov, V. Yu. Kovtun, et al., Radiats. Biol. Radioekol. 44 (1), 68 (2004).
M. V. Vasin, I. B. Ushakov, E. P. Korovkina, and V. Yu. Kovtun, Radiats. Biol. Radioekol. 44 (3), 333 (2004).
M. V. Vasin, I. B. Ushakov, and V. Yu. Kovtun, Vopr. Onkol. 62 (3), 406 (2016).
I. Aoki, N. Abe, and K. Toyama, Nihon Ketsueki Gakkai Zasshi 48 (5), 1154 (1985).
A. Graul-Conroy, E. J. Hicks, and W. E. Fahl, Int. J. Cancer 138 (12), 3011 (2016).https://doi.org/10.1002/ijc.30037
W. E. Fahl, Arch. Dermatol. Res. 308 (10), 751 (2016). https://doi.org/10.1007/s00403-016-1691-2
A. Graul-Conroy, M. Hoover-Regan, K. B. DeSantes, et al., Integr. Cancer Sci. Ther. 5 (6), 10 (2018). https://doi.org/10.15761/ICST.1000293
J. F. Cleary, A. M. Anderson, J. C. Eickhoff, et al., Radiat. Oncol. 12 (1), 201 (2017). https://doi.org/10.1186/s13014-017-0940-7
M. V. Vasin, I. B. Ushakov, L. V. Koroleva, and V. V. Antipov, Radiats. Biol. Radioekol. 39 (2–3), 238 (1999).
M. V. Vasin, V. Yu. Solov’ev, V. N. Mal’tsev, et al., Med. Radiol. Radiats. Bezop. 63 (6), 71 (2018).
C. van der Meer and D. W. van Bekkum, Int. J. Radiat. Biol. 1 (1), 5 (1959).
P. G. Zherebchenko and N. N. Suvorov, Radiobiolo-giya 3 (4), 595 (1963).
S. P. Yarmonenko, Yu. I. Rampan, B. B. Karochkin, et al., Radiobiologiya 10 (5), 700 (1970).
R. L. Prewitt and X. J. Musacchia, Int. J. Radiat. Biol. 27, 181 (1975). https://doi.org/10.1080/09553007514550181
H. van den Brenk and D. Jamieson, Int. J. Radiat. Biol. 4 (4), 379 (1962).
H. van den Brenk and R. Moore, Nature 183 (4674), 1530 (1959).
M. V. Vasin, Radiobiologiya 26 (4), 563 (1986).
G. J. Maestroni, and A. Conti, Exp. Hematol. 22 (3), 313 (1994).
G. J. M. Maestroni, Neuroimmune Pharmacol. 15 (1), 82 (2020). https://doi.org/10.1007/s11481-019-09840-7
J. Han, Z. Zou, C. Zhu, et al., Arch. Biochem. Biophys. 490 (2), 96 (2009). https://doi.org/10.1016/j.abb.2009.08.009
L. Sterin-Borda, C. Furlan, B. Orman, and E. Borda, Biochem. Pharmacol. 74 (9), 1401 (2007).
I. B. Smirnova, G. V. Dontsova, M. I. Yanushevskaya, and E. Ya. Graevskiii, Radiobiologiya 15 (5), 680 (1975).
E. I. Yartsev, V. I. Kulinskii, S. D. Novosel’tseva, and V. G. Yashunskii, Radiobiologiya 19 (2), 229 (1979).
E. G. Skurikhin, E. S. Khmelevskaya, O. V. Pershina, et al., Byull. Eksp. Biol. Med. 10 (3), 128 (2010).
A. Spiegel, S. Shivtiel, A. Kalinkovich, et al., Nat. Immunol. 8 (10), 1123 (2007).
Y. Katayama, M. Battista, W. M. Kao, et al., Cell. 124 (2), 407 (2006). https://doi.org/10.1016/j.cell.2005.10.041
A. Recalde, A. Richart, C. Guerin, et al., Arterioscler. Thromb. Vasc. Biol. 32 (3), 643 (2012). https://doi.org/10.1161/ATVBAHA.111.244392
K. Lapid, T. Itkin, G. D’Uva, et al., J. Clin. Invest. 123 (4), 1705 (2013). https://doi.org/10.1172/JCI64149
Y.-J. Lee, H. S. Kim, H. S. Seo, et al., PPAR Res. 2020, 3785137 (2020). https://doi.org/10.1155/2020/3785137
V. I. Kulinskii and V. G. Yashunskii, Radiobiologiya 18 (5), 667 (1978).
M. Nakaoka, E. Iwai-Kanai, and M. Katamura, Biochem. Biophys. Res. Commun. 456 (1), 250 (2015). https://doi.org/10.1016/j.bbrc.2014.11.067
V. I. Kulinskii and L. I. Zolochevskaya, Radiobiologiya 13 (3) 373 (1973).
A. A. Orlovskii and L. M. Rozhdestvenskii, Radiobiologiya 25 (2) 230 (1985).
M. V. Vasin, I. B. Ushakov, V. Yu. Kovtun, et al., J. Radioprot. Res. 2 (2), 3 (2014).
K. A. Dora, S. M. Richards, S. Rattigan, et al., Am. J. Physiol. 262 (3), H698 (1992). https://doi.org/10.1152/ajpheart.1992.262.3.H698
L. I. Zolochevskaya, Radiobiologiya 13 (6), 926 (1973).
M. Praslicka, M. Hill, and L. Novak, Int. J. Radiat. B-iol. Relat. Stud. Phys. Chem. Med. 4, 567 (1962). https://doi.org/10.1080/09553006214550381
A. Vacek and D. Rotkovska, Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 8, 285 (1964). https://doi.org/10.1080/09553006414550301
M. Okuda, H. C. Lee., C. Kumar, and B. Chance, Acta Physiol. Scand. 145 (2), 159 (1992).
L. A. Orbeli, Fiziol. Zh. SSSR 35 (5), 594 (1949).
V. I. Kulinskii, A. D. Klimova, V. G. Yashunskii, et al., Radiobiologiya 26 (1), 11 (1986).
V. I. Kulinskii, A. K. Kuntsevich, and L. V. Trufanova, Bull. Exp. Biol. Med. 92 (8), 1042 (1981).
V. I., Kulinskii and L. V. Trufanova, Dokl. Akad. Nauk SSSR 224 (6), 1439 (1975).
M. V. Vasin, I. B. Ushakov, E. P. Korovkina, and V. Yu. Kovtun, Bull. Exp. Biol. Med. 155 (3), 360 (2013).
E. Nisoli and M. O. Carruba, J. Cell Sci. 119, 2855 (2006). https://doi.org/10.1242/jcs.03062
C. Sarbu, and D. Casoni, Cent. Eur. J. Chem. 11 (5) 679 (2013). https://doi.org/10.2478/s11532-013-0210-y
H. Zhu, S. McElwee-Witme, and M. Perrone, Cell Death Differ. 7, 773 (2000).
H. Gao, L. Chen, and H. T. Yang, Cardiovasc. Res. 75, 584 (2007).
R. Naderi, A. Imani, M. Faghihi, and M. Moghimian, J. Surg. Res. 164 (1), e37 (2010). https://doi.org/10.1016/j.jss.2010.04.060
X. Y. Wang, J. Yu, F. Y. Zhang, et al., Int. J. Radiat. Oncol. Biol. Phys. 104 (3) 644 (2019). https://doi.org/10.1016/j.ijrobp.2019.02.048
Z. Ju, H. Li-chi, W. Yi-fei, and Y. Xiao-xu, Chinese J. Tissue Eng. Res. 22 (8), 1161 (2018). https://doi.org/10.3969/j.issn.2095-4344.0814
A. Garten, S. Schuster, M. Penke, et al., Nat. Rev. Endocrinol. 11 (9), 535 (2015). https://doi.org/10.1038/nrendo.2015.117
B. Xiang, L. Han, X. Wang, et al., Int. J. Radiat. Oncol. Biol. Phys. 96 (3), 538 (2016). https://doi.org/10.1016/j.ijrobp.2016.06.2442
N. B. Ruderman, X. J. Xu, L. Nelson, et al., Am. J. Physiol. Endocrinol. Metab. 298 (4), E751 (2010) https://doi.org/10.1152/ajpendo.00745.2009
A. Kauppinen, T. Suuronen, and J. Ojala, Cell Signaling 25 (10), 1939 (2013). https://doi.org/10.1016/j.cellsig.2013.06.007
C. K. Singh, G. Chhabra, and A. Ndiaye, Antioxid. Redox Signaling 28 (8), 643 (2018). https://doi.org/10.1089/ars.2017.7290
R. M. Nagler and D. Laufer, Int. J. Radiat. Oncol. Biol. Phys. 40, 477 (1998).
B. Xiang, Y.-J. LIm., and X.-B. Zhao, Exp. Ther. Med. 5 (3), 875 (2013).
B. Xiang, Y.-J. LIm., and X.-B. Zhao, Radiat. Res. 183 (6), 693 (2015). https://doi.org/10.1667/RR13890.1
J. C. Elverdin, M. O. Kaniucki, F. J. Stefano, and V. J. Perec, Acta Odontol. Latinoam. 5 (1), 31 (1990).
N. R. Bruchas, N. L. Toews, C. S. Bockman, and P. W. Abel, Eur. J. Pharmacol. 578 (2–3), 349 (2008). https://doi.org/10.1016/j.ejphar.2007.09.029
M. V. Vasin, T. S. Gan’shina, R. S. Mirzoyan, et al., Bull. Exp. Biol. Med. 165 (3), 364 (2018).
R. Nagler, Y. Marmary, P. C. Fox, et al., Radiat. Res. 147, 468 (1997).
J.-S. Wu, T.-N. Lin, and K. K. J. Wu, Cell Physiol. 220 (1), 58 (2009). https://doi.org/10.1002/jcp.21730
D. M. Valks, S. A. Cook, F. H. Pham, et al., Mol. Cell Cardiol. 34 (7), 749 (2002). https://doi.org/10.1006/jmcc.2002.2014\
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. This article does not contain any studies involving animals performed by any of the authors.
Additional information
Translated by D. Novikova
Abbreviations: PPAR—peroxisome proliferator-activated receptors; AMPK, AMP-activated protein kinase; PGC-1α—peroxisome proliferator-activated receptor gamma coactivator 1‑alpha; PI3K—phosphoinositide 3-kinases; NAMPT—nicotinamide phosphoribosyltransferase.
Rights and permissions
About this article
Cite this article
Vasin, M.V., Ushakov, I.B. An Analysis of the Role of Bioenergetic Processes under Radioprotective Effects Mediated by Alpha1-Adrenergic Agonists. BIOPHYSICS 66, 502–507 (2021). https://doi.org/10.1134/S0006350921030210
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350921030210